Human Neprilysin-2/MMEL1 Antibody, R&D Systems™

Neprilysin-2/MMEL1

Polyclonal

Unconjugated

AAL08942

MMEL1

Mouse myeloma cell line NS0-derived recombinant human Neprilysin-2/MMEL1 Gly69-Trp770 Accession # AAL08942

100 μg

Primary

Detects human Neprilysin-2/MMEL1 in direct ELISAs and Western blots. In direct ELISAs, approximately 5% cross-reactivity with recombinant human (rh) Neprilysin is observed and less than 1% cross-reactivity with rhECE-1 and rhECE-2 is observed.

Human

IgG

Western Blot, Flow Cytometry, Immunoprecipitation, CyTOF

LYOPH

Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunoprecipitation 25 ug/mL, CyTOF-ready

EC 3.4.24, EC 3.4.24.11, MELL1, membrane metallo-endopeptidase-like 1, Membrane metallo-endopeptidase-like 2MGC119455, MGC119454, MMEL1, MMEL2, NEP2, NEP2(m), NEPIIMGC119456, Neprilysin II, neprilysin-2, Neprilysin2, NL2, NL2NL1, SEP, soluble secreted endopeptidase, zinc metallopeptidase

Goat

Affinity Purified

RUO

79258

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.